Aristada and Appetite - increased - a phase IV clinical study of FDA data

Summary:

Appetite - increased is reported as a side effect among people who take Aristada (aripiprazole lauroxil), especially for people who are male, 20-29 old, have been taking the drug for < 1 month also take Abilify, and have Schizophrenia.

The phase IV clinical study analyzes which people have Appetite - increased when taking Aristada. It is created by eHealthMe based on reports of 4,226 people who have side effects when taking Aristada from the FDA, and is updated regularly.

What is Aristada?

Aristada has active ingredients of aripiprazole lauroxil. eHealthMe is studying from 4,234 Aristada users. Check the latest studies of Aristada.

What is Appetite - increased?

Appetite - increased (increased appetite is when you want to eat much more often or in larger quantities than your body requires) is found to be associated with 1,616 drugs and 2,023 conditions by eHealthMe. Check the latest studies of Appetite - increased.

On Jul, 10, 2026

4,226 people reported to have side effects when taking Aristada.
Among them, 63 people (1.49%) have Appetite - increased.

Could Aristada cause Appetite - increased?

Among these 63 people:

How long have people been on Aristada when they have Appetite - increased? *

What is the gender of people who have Appetite - increased when taking Aristada? *

female: 41.94 %
male: 58.06 %

What is the age of people who have Appetite - increased when taking Aristada? *

What are other drugs people take besides Aristada? *

What are other side effects people have besides Appetite - increased? *

Weight Increased: 41 people, 65.08%
Fatigue (feeling of tiredness): 18 people, 28.57%
Agitation (state of anxiety or nervous excitement): 18 people, 28.57%
Insomnia (sleeplessness): 17 people, 26.98%
Drowsiness: 16 people, 25.40%
Hallucination, Auditory (perceiving sounds without auditory stimulus): 12 people, 19.05%
Apathy: 12 people, 19.05%
Stress And Anxiety: 11 people, 17.46%
Abnormal Behavior: 10 people, 15.87%
Decreased Activity: 8 people, 12.70%

What are the existing conditions these people have? *

Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 43 people, 68.25%
Bipolar Disorder (mood disorder): 5 people, 7.94%
Schizoaffective Disorder (a mental disorder characterized by disordered thought): 4 people, 6.35%
Bipolar I Disorder (mood disorder that is characterized by at least one manic or mixed episode): 4 people, 6.35%
Schizoaffective Disorder Bipolar Type (mental illness featuring schizophrenia and a mood disorder with mania): 3 people, 4.76%
Depression: 3 people, 4.76%
High Blood Pressure: 3 people, 4.76%
High Blood Cholesterol: 3 people, 4.76%
Sleep Disorder: 3 people, 4.76%
Stress And Anxiety: 3 people, 4.76%

* Approximation only. Some reports may have incomplete information.

Do you take Aristada and have Appetite - increased?

- Check whether Appetite - increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Aristada:

Aristada (4,234 reports)

Browse all side effects of Aristada:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Appetite - increased:

Appetite - increased (1,616 drugs)

Browse all the conditions that are associated with Appetite - increased:

Appetite - increased (2,023 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on aripiprazole lauroxil (the active ingredients of Aristada) and Aristada (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.